<unk>  refers to a chemotherapeutic regimen consisting of lenalidomide (revlimid), rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolonegiven  every<unk>  days  has high activity in relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
LR-CHOP-21 regimen
VR-CHOP regimen
R-CHOP regimen
CHOP regimen
DBVE-PC regimen
CyBorD regimen
CBV regimen
R-CDOP regimen